BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2022.
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2367-2379
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2367
Table 4 Follow-up status of patients 1 and 3 mo after operation, n (%)
Follow-up status
D-TACE (15 cases)
C-TACE (58 cases)
χ2 value
P value
Efficacy evaluation one month postoperative3.3070.347
CR2 (13.3)20 (34.5)
PR8 (53.3)21 (36.2)
SD3 (20.0)7 (12.1)
PD2 (13.3)10 (17.2)
Evaluation of curative effect in 3 mo postoperative4.0910.252
CR2 (13.3)18 (31.0)
PR7 (46.7)21 (36.2)
SD0 (0.0)5 (8.6)
PD6 (40.0)14 (24.1)
Number of interventional treatments10.4440.005
115 (100.0)32 (55.2)
20 (0.0)24 (41.4)
30 (0.0)2 (3.4)


Write to the Help Desk